14 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

AirFit F20

FDA 510(k)
FDA Class 2 ·Anesthesiology

FORMATK MAGMA PLATFORM LASER

FDA Adverse Event
Injury ·FORMATK SYSTEMS LTD.·Product code GEX·December 19, 2019

HUMAPEN MEMOIR

FDA 510(k)
FDA Class 2 ·General Hospital

PRECISION PORTABLE OXYGEN CONCENTRATION MODEL 4150

FDA 510(k)
FDA Class 2 ·Anesthesiology

DEXCOM G6 CONTINUOUS GLUCOSE MONITORING SYSTEM

FDA Adverse Event
Malfunction ·DEXCOM, INC.·Product code QBJ·June 28, 2024

FORMATK MAGMA PLATFORM

FDA Adverse Event
Malfunction ·FOMATK SYSTEMS, LTD·Product code GEX·January 8, 2020

ATTAIN ABILITY

FDA Adverse Event
Malfunction ·MPRI·Product code OJX·June 8, 2013

COGNIS

FDA Adverse Event
Malfunction ·GUIDANT CRM CLONMEL IRELAND·Product code NIK·July 7, 2011

*

FDA Adverse Event
Injury ·COVIDIEN LP, FORMERLY KNOW AS VALLEYLAB, A DIVISON·Product code ODR·August 6, 2008

Precise Digital Accelerator Intended to be used for radiation therapy treatments of malignant neoplastic diseases, as determined by a licensed medical practitioner.

FDA Enforcement
Class II ·Terminated·Elekta, Inc.·February 18, 2015

FUSION 8MM-40CM UNSUPP PERIPHERAL GRAFT

FDA Adverse Event
Malfunction ·MAQUET CV·Product code DSY·February 8, 2017

ProScreen 10 Panel Dip Card w/Adult, Item No. PSDA-10MO, PSDA-10MMO300, PSDA-10PPX, PSDA-10BUP, PSD-12BUP, PSD-10M, PSCupA-6MB-W, PSCup-10MMO300, PSD-5AB, PSD-10CMO3, PSCupA-10MO, PSCupA-12M-W I-DXA-1127-023, PSCupA-12TBU.

FDA Enforcement
Class III ·Terminated·Ameditech Inc·December 30, 2015

ELEKTA LIMITED Versa HD, REF XRT 2121, 2131; Medical Charged-Particle Radiation Therapy System Accelerator, Linear

FDA Enforcement
Class II ·Ongoing·Elekta, Inc.·December 13, 2023

CADD-Solis VIP ambulatory Infusion Pumps, Model 2110. Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024